OFFICIAL PUBLICATION OF

by its subsidiary APPco

New therapies for hep C listed

AJP Staff 18/04/2016

New therapies have been PBS listed for the treatment of genotype 1 chronic hepatitis C virus. AbbVie Australia today announced that Viekira Pak (ombitasvir, paritaprevir, ritonavir tablets; dasabuvir tablets) and Viekira Pak-RBV (ombitasvir/paritaprevir/ritonavir tablets; dasabuvir tablets with ribavirin) will be listed on the PBS from 1st May 2016. The two therapies are approved for use

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

What does the future look like for CWH/Sigma shareholders?

But doesn’t this change as they slowly cripple their competition? It’s the classic Walmart move. Walk in, kill the competition…

John Smith

What does the future look like for CWH/Sigma shareholders?

I’m not sure if I’m just cynical but Ponraj came across as incredibly naive in this article. He was surprised…

John Smith

‘Doctor of Pharmacy’ title announced

Will any of this lead to direct claiming from Medicare for our new doctors?

John Smith

‘Doctor of Pharmacy’ title announced

Does it come with an ability for the Dr. to claim directly from Medicare? No of course not. Our fearless…

John Smith

New therapies for hep C listed

Previous New chemo listing in indolent Non-Hodgkin’s Lymphoma

Next Cardiac rehabilitation programs needed

In the beginning

The signs of ageing

Hyperpigmentation

How to avoid dry skin

MENU

Previous New chemo listing in indolent Non-Hodgkin’s Lymphoma

Next Cardiac rehabilitation programs needed

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.